Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation

BACKGROUND: In the recent ESC/EACTS guidelines, left atrial appendage (LAA) occlusion or exclusion in patients undergoing (thoracoscopic) atrial fibrillation (AF) ablation surgery is recommended. The Watchman device (WD, Boston Scientific, Minnesota) has proved to reduce the risk of thromboembolic e...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Interv Cardiol
Auteurs principaux: Vroomen, Mindy, Maesen, Bart, Luermans, Justin G., Crijns, Harry J., Maessen, Jos G., La Meir, Mark, Pison, Laurent
Format: Artigo
Langue:Inglês
Publié: Hindawi 2019
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739757/
https://ncbi.nlm.nih.gov/pubmed/31772531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4525084
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires